Related Experiment Video
Updated: Aug 7, 2026
05:12
Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
Published on: May 12, 2023
Solitary autonomously functioning thyroid lesions. Diagnosis, clinical features and pathogenetic considerations
The American Journal of Medicine
|June 1, 1975
Summary
This 12-year study on autonomously functioning thyroid lesions (AFTL) found that observation is suitable for nontoxic AFTL, while toxic AFTL often require radioiodine or surgery. Thyroid cancer was noted in surgically treated patients.
Area of Science:
- Endocrinology
- Oncology
- Nuclear Medicine
Background:
- Autonomously functioning thyroid lesions (AFTL) are common endocrine abnormalities.
- Distinguishing between toxic and nontoxic AFTL is crucial for appropriate management.
- Previous studies have highlighted diagnostic challenges and treatment outcomes for AFTL.
Purpose of the Study:
- To evaluate the long-term outcomes of patients with autonomously functioning thyroid lesions (AFTL).
- To assess the diagnostic accuracy of imaging modalities and the efficacy of different treatment strategies for AFTL.
- To investigate the potential association between AFTL and thyroid cancer.
Main Methods:
- Retrospective analysis of 164 patients with AFTL (140 nontoxic, 24 toxic) over 12 years.
- Utilized suppression procedures, thyroid stimulating hormone scans, ultrasound, and serum hormone level measurements (T3, thyroxine).
- Documented treatment modalities including radioiodine, surgery, and observation, along with patient follow-up.
Main Results:
- Women predominated in both nontoxic (13:1) and toxic (3.8:1) AFTL groups.
- Larger and toxic lesions were associated with older patients.
- Ultrasound demonstrated higher sensitivity than scanning for detecting cystic degeneration.
- Observation of nontoxic AFTL showed no progression to hyperthyroidism, but some lesions increased in size or degenerated.
- Radioiodine was used for 20/24 toxic AFTL patients; surgery for the remaining 4, preferred under age 40.
- Thyroid cancer was found in 3/29 surgically treated patients.
Conclusions:
- Nontoxic AFTL can be managed conservatively with observation, monitoring for potential growth or degeneration.
- Toxic AFTL management depends on patient age, with surgery preferred for younger individuals (<40 years).
- The observed association between AFTL and thyroid cancer warrants further investigation due to shared histologic and pathophysiologic features.
Related Concept Videos
01:23The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:23Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...